METABOLIX (NASDAQ:MBLX)
10.45
+0.41 (4.08%)
| METABOLIX (NASDAQ:MBLX) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $10.04 | 52 Week High | $13.45 | ||
| Open | $10.03 | 52 Week Low | $4.62 | ||
| Day High | $10.50 | P/E | N/A | ||
| Day Low | $9.80 | EPS | $-1.62 | ||
| Volume | 118,082 | ||||
| More MBLX Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| STV | 2 | TGIC | 2 |
| CLWR | 2 | SMI | 1 |
| RAH | 1 | SMOD | 1 |
| ADM | 1 | SNN | 1 |
| BITS | 1 | SNY | 1 |
| BOBE | 1 | CHLN | 1 |
Entities who have mentioned MBLX
- Jefferies & Co | View Related Stories »
- Thomas Weisel Partners Group | View Related Stories »
- Morgan Stanley | View Related Stories »
- Lehman Brothers | View Related Stories »
- 13G | View Related Stories »
- Wachovia | View Related Stories »
- Lone Star Funds | View Related Stories »
- Piper Jaffray | View Related Stories »
- Goldman Sachs Conviction Sell List | View Related Stories »
- After-Hours Movers | View Related Stories »
- B. Riley | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
View All Major News StreetInsider.com Major News for MBLX
- Metabolix (MBLX) Reports Better-Than-Expected Q3 Loss of $0.41
- Metabolix (MBLX) Tops Q3 EPS by 4c
- Metabolix (MBLX) Tops Q2 View By 2c
View All ReportsStreetInsider.com Reports on MBLX
- Metabolix (MBLX) Prices 3.45M Shares at $9/Share
- Morning Movers 11/11: NCST, SMI, MSN, CHLN, NLST, REGN Higher; TGIC, STS, CLWR, STV, MHR, MBLX Lower
- Metabolix (MBLX) Announces 3M Common Share Offering at $9/Share
- After-Hours Movers 11/10: BITS, GSB, OCNF, HOO Higher; TGIC, MCZ, STV, MBLX, EM Lower
- Metabolix (MBLX) Commences Common Stock Public Offering
View All Press ReleasesCompany Press Releases on MBLX
- Metabolix Announces Completion of Common Stock Offering
- Metabolix Prices Common Stock Offering
- Metabolix Announces Commencement of Public Offering of Common Stock
- Metabolix Reports Third Quarter Financial Results and Provides Business Update
- Metabolix and ADM Appoint Stan Haftka as Director of Business Development, Europe, for Telles Joint Venture
StreetInsider Reports on MBLX by Category
View All BlogsBlogs on MBLX
- Metabolix: Plastic from Tobacco
- Big Movers in Healthcare - JAZZ, HEB, MNTA, MBLX and OCLS
- 30 Possible Pandemic Profit Plays: Bullish Biotech and Drug Stocks to Watch
- Burgeoning Bioplastics: Metabolix's Breakthrough
- Analyst upgrades, downgrades and initiations: ABMD, TI, DKS, SCHW ...
View All FilingsSEC Filings on MBLX
- Form 10-Q METABOLIX, INC. For: Sep 30
- Form 8-K METABOLIX, INC. For: Oct 29
- Form 4 METABOLIX, INC. For: Oct 19 Filed by: van Walsem Johan
- Form 4 Cecil Sarah P For: Oct 12
- Form SC 13G/A METABOLIX, INC. Filed by: ALGER FRED MANAGEMENT INC
Comments on MBLX
No comments are currently available.
